View all studies | Adult Migraine - McFarland Clinic

Migraine Research Studies

This research study is evaluating the safety and effectiveness of an investigational study drug for the prevention of migraine in adults with episodic migraine.

Episodic Migraine (EM) which occurs less frequently than Chronic Migraine (CM) also has an impact on one’s quality of life and the need for alternative treatment options is essential to potentially help manage migraines in people suffering from EM.

This study may be an option for you if you:

  • Are aged 18-65 years
  • Have a history of migraine headache disorder
  • Had migraine onset before 50 years of age
  • Have 6-14 migraine days per month
  • Have <15 headache days per month

Other criteria apply.

If you are eligible, your total involvement in the study may last up to 52 weeks (1 year) and you will receive study-related evaluations and care at no cost. You may be compensated for your time and travel.

Submit to learn more:

When you register your interest with Accellacare, our clinical research specialists will review your information at no cost and connect you with studies you may be eligible for. When we find a match, Accellacare may contact you for further pre-screening or we may share your information with a local site office for them to contact you directly. Your data will be processed as outlined in the Accellacare Privacy Notice.

Data Protection

As the data controller for the, Accellacare is committed to protecting the information that you provide. Where you give us your consent, we may use your information to: (a) identify appropriate clinical trials for you and to let you know about them; and/or (b) send you invitations to participate in future study opportunities. You can withdraw your consent at any time, but we may continue some limited processing where we have other legal grounds for doing so.

Please enter the security code:

Please note: You may or may not benefit medically from taking part and you are able to opt at out anytime and do not have to give us a reason for doing so. Trial participation will be in collaboration with your GP.